MedPath

Betaxolol

Approved
Approval ID

1fc0a413-4e6b-4ed7-9957-ace4c8cfab55

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 23, 2022

Manufacturers
FDA

Akorn

DUNS: 117696770

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Betaxolol Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17478-705
Application NumberANDA075386
Product Classification
M
Marketing Category
C73584
G
Generic Name
Betaxolol Hydrochloride
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMay 23, 2022
FDA Product Classification

INGREDIENTS (6)

Betaxolol HydrochlorideActive
Quantity: 5 mg in 1 mL
Code: 6X97D2XT0O
Classification: ACTIM
Edetate DisodiumInactive
Code: 7FLD91C86K
Classification: IACT
Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT
Benzalkonium ChlorideInactive
Code: F5UM2KM3W7
Classification: IACT
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Betaxolol - FDA Drug Approval Details